Building a Patient-Powered Research Engine: Lessons from a Global IBD Cohort
A large-scale, investigator-initiated study demonstrates the feasibility and challenges of long-term, patient-driven data collection in chronic inflammatory disease. The I-CARE cohort enrolled over 12,800 patients with inflammatory bowel disease (IBD) across 15 countries, who submitted monthly electronic patient-reported outcomes (ePROs) for up to six years. The research highlights high initial patient engagement, with over three-quarters of participants submitting data, but also identifies predictors of early withdrawal, such as younger age and unemployment. Crucially, the study reveals a significant role for investigator oversight, with clinicians correcting over half of patient-reported cancer events and nearly 20% of biologic treatment sequences, underscoring the need for validation in real-world evidence generation.
Why it might matter to you: For immunology researchers focused on chronic inflammation and adaptive immunity, this study provides a robust framework for collecting real-world longitudinal data on disease activity and treatment response. The validation gap between patient-reported outcomes and clinician assessment, particularly for serious events, highlights a critical methodological consideration for your own studies involving patient-generated data. This model directly informs the design of future decentralized trials and observational studies in autoimmunity, potentially accelerating evidence development for novel immunomodulators and biologics.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
